Sorrel Medical

Wearable Drug-delivery Platform

Health Tech & Life Sciences
Acquired (Inactive) by LTS Lohmann Therapie-System on Jun 2023 - closed due to acquisition

Company Overview

Snapshot

Founded in March 2015, Sorrel Medical operates with 11–50 employees. The company was acquired by LTS Lohmann Therapie-System in June 2023, marking a significant exit in the Health Tech & Life Sciences sector.

Business overview

Sorrel Medical specializes in developing and manufacturing wearable drug-delivery devices. Its platform is designed for the subcutaneous delivery of injectable drugs, biologics, and biosimilars, aiming to enhance the patient experience and provide value for pharmaceutical companies. The company serves the Health Tech & Life Sciences sector, focusing on digital healthcare, drug delivery, and medical technologies.

Strategic signal

In June 2023, Sorrel Medical's wearable drug pump business was acquired by LTS Lohmann Therapie-System. This acquisition highlights the increasing consolidation and strategic interest in the wearable drug delivery market, signaling strong validation for innovative solutions in at-home patient care and pharmaceutical administration.

Company Intelligence Q&A

What is Sorrel Medical's primary focus?
Sorrel Medical develops and manufactures wearable drug-delivery devices designed to optimize the patient experience and value for pharmaceutical companies. Its platform facilitates the subcutaneous delivery of injectable drugs, biologics, and biosimilars.
When was Sorrel Medical founded?
Sorrel Medical was founded in March 2015.
What was a significant corporate milestone for Sorrel Medical?
In June 2023, Sorrel Medical was acquired by LTS Lohmann Therapie-System. This acquisition led to the company's current status as Acquired (Inactive).
What recognition did Sorrel Medical's platform receive?
In June 2019, Sorrel Medical's wearable drug delivery platform won the 2019 MedTech Breakthrough Award.
Did Sorrel Medical expand its manufacturing capabilities?
In July 2020, Sorrel Medical opened a new manufacturing facility, increasing its clinical and commercial supply capabilities for wearable drug delivery devices.

External links